Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcript
Yield10 Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.11. Yield10 Bioscience, Inc.
Yield10 Bioscience Inc. (YTEN)
Market is closed
Sector: Agricultural Production-Crops
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GMT Capital Thomas E. Claugus | 0 | $0 | 0% | |
| 2. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 3. | Birchview Capital Matthew Strobeck | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.65 | 765,000 | $497,250.00 | 1,637,956 | 2023-08-15 | Filing | |
| $2.98 | 335,570 | $999,998.60 | 962,956 | 2023-05-05 | Filing | |
| $2.80 | 2,000 | $5,599.20 | 17,309 | 2022-08-17 | Filing | |
| $2.85 | 2,000 | $5,698.00 | 15,309 | 2022-08-16 | Filing | |
| $2.77 | 2,000 | $5,530.00 | 13,309 | 2022-08-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.20 | 36,000 | $7,200.00 | 63,789 | 2023-12-20 | Filing | |
| $0.21 | 36,000 | $7,430.40 | 1,566,956 | 2023-12-19 | Filing | |
| $0.24 | 35,000 | $8,319.50 | 1,602,956 | 2023-12-08 | Filing | |
| $0.30 | 37,931 | $11,447.58 | 872,956 | 2023-10-06 | Filing | |
| $0.30 | 10,670 | $3,215.94 | 910,887 | 2023-10-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to the Third Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience.
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Second Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode.
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q1 2023 Earnings Call Transcript
Operator: Welcome to the First Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode.
Hedge Fund and Insider Trading News: Oasis Management, Alden Global Capital, Knighthead Capital Management, Calculo Capital, Caesars Entertainment Inc (CZR), Bristol-Myers Squibb Company (BMY), and More
Please don’t feed or throw objects at the fund managers.
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2022 Earnings Call Transcript
Operator: Greeting and welcome to the Fourth Quarter 2022 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode.
10 GMO Stocks to Invest in Now
A genetically modified organism (GMO) is developed by utilizing genetic engineering techniques that modify an organism’s genetic structure, with genes that can be crossed among different species or ...
Hedge Funds Watching Yield10 Bioscience, Inc. (YTEN) From Afar
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking.
Hedge Fund and Insider Trading News: Mark Nordlicht, Alec Litowitz, Highbridge Capital Management, Cornerstone Building Brands Inc (CNR), Middlesex Water Company (MSEX), and More
NEW YORK (Reuters) - Mark Nordlicht, the founder of defunct hedge fund firm Platinum Partners, was found guilty on Tuesday of defrauding bondholders of an oil exploration company Platinum controlled, ...
13D Filing: Birchview Capital and Yield10 Bioscience Inc. (YTEN)
Underwriting Agreement, dated as of December 19, 2017, by and between Yield10 Bioscience, Inc. and Ladenburg Thalmann & Co. Inc.
Billionaire Hedge Funds
